Roger Sidhu is Chief Medical Officer of Brooklyn ImmunoTherapeutics, Inc.. Currently has a direct ownership of 20,163 shares of BTX, which is worth approximately $0. The most recent transaction as insider was on Sep 20, 2022, when has been sold 20,163 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.2K
0% 3M change
0% 12M change
Total Value Held $0

Roger Sidhu Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 20 2022
BUY
Exercise of conversion of derivative security
-
20,163 Added 50.0%
20,163 Common Stock
RS

Roger Sidhu

Chief Medical Officer
San Diego, CA

Track Institutional and Insider Activities on BTX

Follow Brooklyn ImmunoTherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BTX shares.

Notify only if

Insider Trading

Get notified when an Brooklyn Immuno Therapeutics, Inc. insider buys or sells BTX shares.

Notify only if

News

Receive news related to Brooklyn ImmunoTherapeutics, Inc.

Track Activities on BTX